← Human Trials & Peer-Reviewed Studies
The Effects of Carnitine Supplementation on Oocytes in Women Undergoing IVF Process
Plain-language guide to NCT07783399: not phased randomized trial of L-Carnitine, 70 participants. Who took part, design and what was measured.
Key Facts
- Registry ID
- NCT07783399
- Phase
- not phased
- Status
- recruiting participants
- Start
- 2026-05-15
- Completion (planned or actual)
- 2026-09-01
- Participants
- 70 (estimated)
- Design
- randomized, open label (everyone knows who gets what), basic_science
- Conditions studied
- Infertility (IVF Patients)
- Results posted
- not yet
What This Study Did, in Plain Language
What Was Tested
The trial (not phased) is built around L-Carnitine.
It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates.
It had two arms (groups): L-Carnitine Group (experimental) and No supplementation (no intervention).
Participants who have not used carnitin supplementation.
The registry classes the interventions as dietary supplement.
Who Took Part
The registry lists 70 planned participants were the target.
It was open to women only aged from 18 years up to 45 years.
Healthy volunteers were not accepted; participants needed the condition being studied.
Examples of who could join: Women undergoing IVF process. Women aged 18-45 years.
The full record lists 2 inclusion and 5 exclusion criteria; among the exclusions: severe kidney disease; liver insufficiency; endocrine disorders.
How the Study Was Run
Design: randomized, parallel-group and open-label.
Because people in this L-Carnitine study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Groups ran in parallel: each of the participants stayed in one arm throughout.
Nothing was hidden in this open-label L-Carnitine study: the participants and staff both knew the treatment.
It started in 2026-05-15 with completion listed for 2026-09-01.
It ran at 1 site in Serbia.
Its stated primary purpose is basic science.
What Was Measured
Primary outcome: The impact of carnitine supplementation on the number of oocytes retrieved during in vitro fertilization and on IVF outcomes (time frame: 3 months). The impact of carnitine supplementation on the number of good quality oocytes (metaphase II (MII) oocytes) retrieved during oocyte pick-up (time frame: 3 months).
What This Means in Plain Language
Put simply, this is a not phased, randomized trial of L-Carnitine in 70 people.
It is still recruiting; no results are posted to the registry yet, so nothing here describes outcomes.
More context: the L-Carnitine compound page, all human trials.
Our Notes on the Compound
L-Carnitine: An amino acid derivative that carries fatty acids into mitochondria for energy production.
Related Pages
Source: ClinicalTrials.gov record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.